PTC Therapeutics, Inc. PTCT
$71.70
-0.38%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-08-13 | View → |
| 4 | Insider transaction | 2026-08-06 | View → |
| 4 | Insider transaction | 2026-07-30 | View → |
| 10-Q | 10-Q | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-30 | View → |
| 4 | Insider transaction | 2026-07-16 | View → |
| 4 | Insider transaction | 2026-07-13 | View → |
| 4 | Insider transaction | 2026-07-13 | View → |
| 4 | Insider transaction | 2026-07-08 | View → |
| 4 | Insider transaction | 2026-07-08 | View → |
| 4 | Insider transaction | 2026-06-30 | View → |
| 4 | Insider transaction | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-06-24 | View → |
| 4 | Insider transaction | 2026-06-22 | View → |
| 4 | Insider transaction | 2026-06-22 | View → |
| 8-K | FORM 8-K | 2026-06-18 | View → |
| 8-K | FORM 8-K | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-09 | View → |
| 8-K | 8-K | 2026-06-05 | View → |
| 4 | Insider transaction | 2026-05-19 | View → |
| 4 | Insider transaction | 2026-05-15 | View → |
| 4 | Insider transaction | 2026-05-12 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-07 | View → |
| 8-K | 8-K | 2026-04-28 | View → |
| 4 | Insider transaction | 2026-04-23 | View → |
| DEF 14A | DEF 14A | 2026-04-20 | View → |
| 4 | Insider transaction | 2026-04-08 | View → |
| 4 | Insider transaction | 2026-04-06 | View → |
| 4 | Insider transaction | 2026-04-03 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 8-K | 8-K | 2026-03-25 | View → |
| 4 | Insider transaction | 2026-03-13 | View → |
| 4 | Insider transaction | 2026-03-12 | View → |
| 4 | Insider transaction | 2026-03-09 | View → |
| 4 | Insider transaction | 2026-03-09 | View → |
| 4 | Insider transaction | 2026-03-09 | View → |
| 4 | Insider transaction | 2026-02-23 | View → |
| 4 | Insider transaction | 2026-02-20 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $71.70
- Market Cap
- $5.98 billion
- 52-Week Range
- $43.17 – $90.87
- Average Volume
- 1.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.